Legal & General Group PLC Akebia Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 18,129 shares of AKBA stock, worth $34,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,129
Previous 18,697 3.04%
Holding current value
$34,807
Previous $24,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$1.26 - $2.13 $715 - $1,209
-568 Reduced 3.04%
18,129 $33,000
Q3 2024

Nov 14, 2024
BUY
$0.94 - $1.55 $686 - $1,131
730 Added 4.06%
18,697 $24,000
Q2 2024

Aug 14, 2024
BUY
$0.86 - $1.63 $15,451 - $29,286
17,967 New
17,967 $18,000
Q3 2022

Nov 14, 2022
SELL
$0.3 - $0.46 $4,182 - $6,413
-13,943 Closed
0 $0
Q2 2022

Aug 22, 2022
SELL
$0.32 - $0.67 $33,048 - $69,194
-103,276 Reduced 88.11%
13,943 $5,000
Q1 2022

May 16, 2022
BUY
$0.72 - $2.93 $3,806 - $15,490
5,287 Added 4.72%
117,219 $84,000
Q4 2021

Feb 14, 2022
BUY
$2.26 - $3.34 $11,044 - $16,322
4,887 Added 4.57%
111,932 $253,000
Q3 2021

Nov 15, 2021
BUY
$2.35 - $3.88 $69,865 - $115,352
29,730 Added 38.45%
107,045 $308,000
Q2 2021

Aug 12, 2021
BUY
$2.83 - $4.2 $122,009 - $181,074
43,113 Added 126.05%
77,315 $293,000
Q1 2021

May 17, 2021
BUY
$2.92 - $5.06 $75 - $131
26 Added 0.08%
34,202 $116,000
Q4 2020

Feb 12, 2021
SELL
$2.22 - $3.78 $721 - $1,228
-325 Reduced 0.94%
34,176 $96,000
Q3 2020

Nov 13, 2020
SELL
$2.39 - $13.08 $9,593 - $52,503
-4,014 Reduced 10.42%
34,501 $87,000
Q2 2020

Aug 14, 2020
BUY
$6.67 - $13.58 $115,764 - $235,694
17,356 Added 82.03%
38,515 $523,000
Q1 2020

May 14, 2020
SELL
$4.1 - $10.24 $20,057 - $50,094
-4,892 Reduced 18.78%
21,159 $161,000
Q3 2019

Nov 13, 2019
BUY
$3.55 - $5.4 $11,782 - $17,922
3,319 Added 14.6%
26,051 $102,000
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $24,345 - $47,800
5,938 Added 35.36%
22,732 $110,000
Q4 2018

Feb 15, 2019
BUY
$5.39 - $9.15 $50,013 - $84,902
9,279 Added 123.47%
16,794 $93,000
Q2 2018

Aug 10, 2018
SELL
$9.15 - $11.34 $6,807 - $8,436
-744 Reduced 9.01%
7,515 $75,000
Q1 2018

May 17, 2018
SELL
$9.53 - $15.68 $27,122 - $44,625
-2,846 Reduced 25.63%
8,259 $79,000
Q4 2017

Feb 13, 2018
BUY
$14.24 - $19.59 $158,135 - $217,546
11,105
11,105 $167,000

Others Institutions Holding AKBA

# of Institutions
128
Shares Held
63.3M
Call Options Held
50.6K
Put Options Held
203K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $353M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email